This tool is available at:

http://aan.com/professionals/practice/guidelines/guideline_summaries/Global_Devlopmental_Delay_Clinicians.pdf

This tool is a summary of the American Academy of Neurology (AAN) and Child Neurology Society (CNS) guideline on diagnosis of the child with global developmental delay. This practice parameter reviewed available evidence concerning the value of diagnostic testing in the initial evaluation of a young child with a global developmental delay that is static, nonprogressive, and has no clear etiology.

Diagnosis
Evaluation
Screening

This summary presents specific recommendations for each of the following testing modalities:

• Metabolic screening
• Cytogenetic testing
• Fragile X testing
• Rett syndrome testing
• Molecular techniques
• Lead screening
• Thyroid screening
• EEG
• Neuroimaging
• Hearing and vision testing

Children, typically age less than or equal to 5 years

Children

Getting Better
Living with Illness

Effectiveness

American Academy of Neurology - Medical Specialty Society
Child Neurology Society - Medical Specialty Society

• Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society.

2003 Feb

This QualityTools summary was completed by ECRI on September 21, 2004.